Skip to main content
. 2012 May 14;2012:607851. doi: 10.1155/2012/607851

Table 2.

Objective responses of liver cirrhosis patients with advanced HCC treated after 4–8 weeks of sorafenib treatment.

Dose of sorafenib PR SO PO Response rate (%)
200 m g (n = 11)
(1 dropout)
0 2 8 0.0
400 mg (n = 27)
(3 dropout)
4 11 9 16.7
800 mg (n = 7)
(0 dropout)
1 3 3 14.3